Japan has always been a good market for orphan drugs. The Japanese organizations that are involved in the process include the MHLW, PMDA and the National Institute of Biomedical Innovation (NIBIO). Orphan drugs must meet the following requirements – 1. less than... Read More
On September 18, China’s National Health Commission (NHC) released its second list of rare diseases. This list includes 86 rare diseases including Giant Cell arteritis, Gorlin Syndrome, Fragile X Syndrome, etc. For a complete list, please click here. It is estimated that... Read More
On July 27, in an effort to reinforce the management and use of pharmaceutical products in many fields, the National Healthcare Commission (NHC) issued the Notice on Further Strengthening Medication Safety Management and Improving the Level of Rational Medication. This notice put special emphasis on pediatric... Read More
To download this report, please click on PBM’s Report on Orphan Drugs and Rare Diseases in China Read More
In an across-the-board effort announced by the Chinese government in May, the country’s health regulators are making plans to strengthen oversight of the manufacture, import and distribution of pharmaceuticals. The announcement from the General Office of the State Council outlined a range... Read More
Moving to improve coordination of all aspects of rare disease research and treatment, India has approved its first-ever national policy on the prevention and management of such conditions, which afflict a small percentage of the population and are costly to remedy. The... Read More
To speed the import of key new biologic agents needed to combat public health emergencies, including vaccines to help the body develop immunity to the virus that causes COVID-19, South Korea is cutting the steps required for regulatory approval of the products. The... Read More
A major state-sanctioned political party in China made up primarily of medical and health science researchers is calling for making rare disease treatments eligible for government health insurance reimbursement. The public plea this spring by the Chinese Peasants and Workers Democratic Party... Read More
A groundbreaking public welfare foundation in China dedicated to combating rare diseases has announced a major effort to help fund treatments for patients afflicted by such disorders. The assistance program is being launched by the Illness Challenge Foundation, which focuses on bettering... Read More
Introduction to China’s Drug Market Everyone has been talking about opportunities in China’s drug market the last 5 years. While the size of the drug market in China varies, we estimate it at about $140 billion dollars now and growing about 10%... Read More